Regents of the University of Minnesota
Minneapolis, Minnesota, United States
University department in Minneapolis, Minnesota
600 McNamara Alumni Center S.E., 200 SE Oak St, Minneapolis, MN 55455
About Regents of the University of Minnesota
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Bayer
1
Boston Scientific Corporation
1
Gamida Cell ltd
1
Janssen Research & Development, LLC
1
Jounce Therapeutics, Inc.
1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1
NuCana plc
1
Urovant Sciences GmbH
1
Clinical Trials at Regents of the University of Minnesota
During the past decade, Regents of the University of Minnesota conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
2015-11-19
2025-04-01
Active, not recruiting
534
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
2018-01-03
2020-04-30
Terminated
334
RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry
2018-02-23
2018-12-12
Terminated
95
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
2019-12-24
2022-03-02
Terminated
775
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041
2020-11-23
2024-06-15
Recruiting
48
Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors
2021-01-12
2024-01-01
Active, not recruiting
281
Composur: Study to Understand the Performance of Vibegron in Participants With Overactive Bladder (OAB)
2021-10-28
2024-09-01
Recruiting
400
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Regents of the University of Minnesota" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Bayer" with 1 trials
sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Gamida Cell ltd" with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Regents of the University of Minnesota"
#1 collaborator was "Biocompatibles UK Ltd" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Regents of the University of Minnesota
According to Clinical.Site data, the most researched conditions in "Regents of the University of Minnesota" are
"Adult Solid Tumor" (1 trials), "Biliary Tract Cancer" (1 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Regents of the University of Minnesota" in a lesser frequency.
Clinical Trials Intervention Types at Regents of the University of Minnesota
Most popular intervention types in "Regents of the University of Minnesota" are "Drug" (8 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Cisplatin" (1 trials), "Entrectinib" (1 trials), "Etrolizumab" (1 trials) and "GDA-201" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regents of the University of Minnesota
The vast majority of trials in "Regents of the University of Minnesota" are
10 trials for "All" genders.
Clinical Trials Status at Regents of the University of Minnesota
Currently, there are NaN active trials in "Regents of the University of Minnesota".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Regents of the University of Minnesota,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Regents of the University of Minnesota, 3 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".